What is the address of CAMBERLIN PERFUSION?

The registered office of CAMBERLIN PERFUSION is located at Ruelle Benjamin(BO) 8, 7110 La Louvière.

Is CAMBERLIN PERFUSION still active?

Yes. According to the CBE (2 November 2026) CAMBERLIN PERFUSION is active, legal situation “Normale toestand”, started on 6 September 2021.

Is CAMBERLIN PERFUSION registered on Peppol?

Yes, CAMBERLIN PERFUSION is registered on the Peppol network with ID 0208:0773572921.

What is the enterprise number of CAMBERLIN PERFUSION?

The enterprise number of CAMBERLIN PERFUSION is BE0773572921.

When was CAMBERLIN PERFUSION founded?

CAMBERLIN PERFUSION was founded on 6 September 2021.

Is CAMBERLIN PERFUSION a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 6 September 2021; 5 annual accounts filed, latest fiscal year 2025; 1 events from the Belgian Official Gazette processed.

How much profit did CAMBERLIN PERFUSION make in 2025?

CAMBERLIN PERFUSION posted a profit after taxes of € 86,037 in financial year 2025.

What is the revenue of CAMBERLIN PERFUSION?

As a small company, CAMBERLIN PERFUSION is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 118,135.

CAMBERLIN PERFUSION (Private Limited) - La Louvière

Dossier CAMBERLIN PERFUSION, printed on 2 November 2026 from databakkes.be/en/0773572921/camberlin-perfusion. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

CAMBERLIN PERFUSION from La Louvière, company number BE0773572921, closed financial year 2025 with a result of € 86,037 after tax. For that financial year CAMBERLIN PERFUSION recorded a gross margin of € 118,135 and equity of € 6,895. Compared with financial year 2024, the result moved from € 89,749 to € 86,037. The company is profitable. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on July 28, 2026.

What it is worth Growing

€ 6,895

▲ 18% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 86,037

▼ 4% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 4,870

▼ 87% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 85,000 paid out

99 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Vehicles and equipment

€ 3,085

▲ 17% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 1,075

▲ 177% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 59,879 Gross margin 2022: € 59,879 First fiscal year in the series	€ 93,787 Gross margin 2023: € 93,787 ▲ 57% vs 2022 (€ 59,879) Favourable step	€ 116,460 Gross margin 2024: € 116,460 ▲ 24% vs 2023 (€ 93,787) Favourable step	€ 118,135 Gross margin 2025: € 118,135 ▲ 1% vs 2024 (€ 116,460) Favourable step	▲ 1%
Profit after taxes	€ 46,708 Profit after taxes 2022: € 46,708 First fiscal year in the series	€ 73,021 Profit after taxes 2023: € 73,021 ▲ 56% vs 2022 (€ 46,708) Favourable step	€ 89,749 Profit after taxes 2024: € 89,749 ▲ 23% vs 2023 (€ 73,021) Favourable step	€ 86,037 Profit after taxes 2025: € 86,037 ▼ 4% vs 2024 (€ 89,749) Unfavourable step	▼ 4%
Equity	€ 60,088 Equity 2022: € 60,088 First fiscal year in the series	€ 133,109 Equity 2023: € 133,109 ▲ 122% vs 2022 (€ 60,088) Favourable step	€ 5,858 Equity 2024: € 5,858 ▼ 96% vs 2023 (€ 133,109) Unfavourable step	€ 6,895 Equity 2025: € 6,895 ▲ 18% vs 2024 (€ 5,858) Favourable step	▲ 18%
Total debts	€ 4,051 Total debts 2022: € 4,051 First fiscal year in the series	€ 2,616 Total debts 2023: € 2,616 ▼ 35% vs 2022 (€ 4,051) Favourable step	€ 50,820 Total debts 2024: € 50,820 ▲ € 48,203 vs 2023 (€ 2,616) Unfavourable step	€ 17,920 Total debts 2025: € 17,920 ▼ 65% vs 2024 (€ 50,820) Favourable step	▼ 65%
Cash	€ 46,581 Cash 2022: € 46,581 First fiscal year in the series	€ 116,960 Cash 2023: € 116,960 ▲ 151% vs 2022 (€ 46,581) Favourable step	€ 38,471 Cash 2024: € 38,471 ▼ 67% vs 2023 (€ 116,960) Unfavourable step	€ 4,870 Cash 2025: € 4,870 ▼ 87% vs 2024 (€ 38,471) Unfavourable step	▼ 87%
Retained profit	€ 55,088 Retained profit 2022: € 55,088 First fiscal year in the series	€ 128,109 Retained profit 2023: € 128,109 ▲ 133% vs 2022 (€ 55,088) Favourable step	€ 858 Retained profit 2024: € 858 ▼ 99% vs 2023 (€ 128,109) Unfavourable step	€ 1,895 Retained profit 2025: € 1,895 ▲ 121% vs 2024 (€ 858) Favourable step	▲ 121%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 0 Dividend 2023: € 0 Unchanged (€ 0) Unchanged	€ 217,000 Dividend 2024: € 217,000 Unchanged (€ 0) Unchanged	€ 85,000 Dividend 2025: € 85,000 ▼ 61% vs 2024 (€ 217,000) Unchanged	▼ 61%
Balance sheet total	€ 64,139 Balance sheet total 2022: € 64,139 First fiscal year in the series	€ 135,726 Balance sheet total 2023: € 135,726 ▲ 112% vs 2022 (€ 64,139) Unchanged	€ 56,678 Balance sheet total 2024: € 56,678 ▼ 58% vs 2023 (€ 135,726) Unchanged	€ 24,814 Balance sheet total 2025: € 24,814 ▼ 56% vs 2024 (€ 56,678) Unchanged	▼ 56%

Key figures of CAMBERLIN PERFUSION, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to CAMBERLIN PERFUSION?

What happened at CAMBERLIN PERFUSION in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 28, 2026 New annual accounts for financial year 2025: profit of € 86,037 (▼ 4% vs 2024). Source: NBB ↗
Sep 10, 2021 New establishment in La Louvière. KBO
Sep 8, 2021 Incorporation, published in the Gazette. Source: Staatsblad ↗

In short

From € 46,708 profit in 2022 to € 86,037 profit in 2025.

Paid € 85,731 in corporate taxes since 2022.

Best year ever: 2024, with € 89,749 profit.

Paid out € 302,000 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Establishments

Establishment units

Physical locations of this company

Registered office

Ruelle Benjamin(BO) 8

7110 La Louvière

2.321.488.330

Rue des Marronniers(Be) 13

7100 La Louvière

Active since 10 September 2021

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Shareholders according to the Official Gazette deeds

Who contributed at incorporation and at capital increases, with the deed as source. Later share transfers are not published in the Gazette.

Incorporation

8 September 2021 Source: Deed ↗

Camberlin Balthazar Pierre Guy(oprichter) 100%

Details

Company number: 0773.572.921
VAT number: BE 0773.572.921
Registered office: Ruelle Benjamin(BO) 8, 7110 La Louvière
Names & denominations: CAMBERLIN PERFUSION
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 6 September 2021
Peppol: Active · Active since 8 Mar 2026

View on CBE Public ↗ Annual accounts (NBB) ↗

CAMBERLIN PERFUSION